Replies to post #285646 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

ae kusterer,

DCVax-L is a needed basic treatment to improve outcomes from use of checkpoint inhibitors with immediate improvement above this by adding ICLC adjuvent and earlier treatment of those who are non responders to chemo/rad. The obvious is just too much to handle by so many. Not for Dr. Ashkan though. Best wishes.